Tremfya and Diverticulitis aggravated - a phase IV clinical study of FDA data

Summary:

Diverticulitis aggravated is reported as a side effect among people who take Tremfya (guselkumab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Albuterol, and have Psoriasis.

The phase IV clinical study analyzes which people have Diverticulitis aggravated when taking Tremfya. It is created by eHealthMe based on reports of 22,544 people who have side effects when taking Tremfya from the FDA, and is updated regularly.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.

What is Diverticulitis aggravated?

Diverticulitis aggravated (digestive disease which involves the formation of pouches (diverticula) within the bowel wall) is found to be associated with 1,203 drugs and 441 conditions by eHealthMe. Check the latest studies of Diverticulitis aggravated.

On Jul, 11, 2026

22,544 people reported to have side effects when taking Tremfya.
Among them, 35 people (0.16%) have Diverticulitis aggravated.

Could Tremfya cause Diverticulitis aggravated?

Among these 35 people:

How long have people been on Tremfya when they have Diverticulitis aggravated? *

What is the gender of people who have Diverticulitis aggravated when taking Tremfya? *

female: 51.61 %
male: 48.39 %

What is the age of people who have Diverticulitis aggravated when taking Tremfya? *

What are other drugs people take besides Tremfya? *

What are other side effects people have besides Diverticulitis aggravated? *

Weight Increased: 2 people, 5.71%
Abscess Intestinal (collections of pus-intestinal): 2 people, 5.71%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 5.71%
Post Procedural Complication: 2 people, 5.71%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 2 people, 5.71%
Herpes Zoster: 2 people, 5.71%
Impaired Gastric Emptying: 1 person, 2.86%
Bronchial Hyperreactivity: 1 person, 2.86%
Colitis (inflammation of colon): 1 person, 2.86%
Diarrhea: 1 person, 2.86%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 17 people, 48.57%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Tremfya and have Diverticulitis aggravated?

- Check whether Diverticulitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tremfya:

Tremfya (22,557 reports)

Browse all side effects of Tremfya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diverticulitis aggravated:

Diverticulitis aggravated (1,203 drugs)

Browse all the conditions that are associated with Diverticulitis aggravated:

Diverticulitis aggravated (441 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on guselkumab (the active ingredients of Tremfya) and Tremfya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.